Document is current
Any future updates will be listed below
-
Authors
Stenhede, Elias
Ravn, Jesper
Schirmer, Henrik
Ranjbar, Arian
-
Funding
Funding for this research was provided by:
Akershus Universitetssykehus
- License Information
-
More Information
Article History
Received: 4 September 2025
Accepted: 11 May 2026
First Online: 19 May 2026
Competing interests
: Henrik Schirmer has previously received lecture fees from Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Novartis, NovoNordisk, and Sanofi. The authors declare no other competing interests.
